Impact of COAPT trial in patients with secondary mitral regurgitation submitted to MitraClip: an exploratory analysis of clinical outcomes in a tertiary care center

Back

HFA Premium Access

Impact of COAPT trial in patients with secondary mitral regurgitation submitted to MitraClip: an exploratory analysis of clinical outcomes in a tertiary care center

Session: Valvular heart disease 2

Topic: Mitral Valve Regurgitation

Speaker: Doctor F. Barbas De Albuquerque (Lisbon, PT)

Event: Heart Failure 2024

Congress Presentation

Add to my library

About the speaker

Doctor Francisco Barbas De Albuquerque

Hospital de Santa Marta, Lisbon (Portugal)

1 presentation

0 follower

5 more presentations in this session

Homozygous familial hypercholesterolemia surgical management and outcomes in up to 23 years follow up: a new Horizon for the Ross Procedure.

Speaker: Professor D. Galzerano (Riyadh, SA)

Insights into ultrasound-guided femoral puncture in transcatheter aortic valve replacement: analyzing vascular complications and mortality rates

Speaker: Doctor C. Gregorio (Lisbon, PT)

Exploring pathophysiological phenotyping and medical optimization in secondary tricuspid valve regurgitation prior to tricuspid valve edge to edge repair

Speaker: Doctor I. Zarifis (London, GB)

Prognostic implications of left atrial volume index in patients with ventricular functional mitral regurgitation underwent transcatheter edge-to-edge repair

Speaker: Doctor M. Maeda (Kumamoto, JP)

Too little, too late: atrial secondary tricuspid regurgitation (A-STR) carries a better prognosis in early-stage heart failure, but not in late-stage

Speaker: Doctor C. Bourg (Rennes, FR)

Access the full session

Valvular heart disease 2

Speakers: Doctor F. Barbas De Albuquerque, Professor D. Galzerano, Doctor C. Gregorio, Doctor I. Zarifis, Doctor M. Maeda...

Access

About the event

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources